REPAGLINIDE vs REPOTRECTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REPAGLINIDE vs REPOTRECTINIB: Safety Overview
| Metric | REPAGLINIDE | REPOTRECTINIB |
|---|---|---|
| Total FAERS Reports | 2,544 | 187 |
| Deaths Reported | 169 | 27 |
| Death Rate | 6.6% | 14.4% |
| Hospitalizations | 1,517 | 48 |
| Average Patient Age | 71.9 yrs | 60.8 yrs |
| % Female Patients | 45.5% | 61.1% |
| FDA Approval Date | Apr 24, 2015 | Jun 11, 2024 |
| Manufacturer | Rising Pharma Holdings, Inc. | E.R. Squibb & Sons, L.L.C. |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Prescription |